Rothfuss Cristin

Rothfuss Cristin is listed in filings as EVP at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 13, 2026, including 17 public disclosures. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT). The current snapshot covers public activity from Nov 29, 2024 to Mar 13, 2026. Reported amounts are shown as $16.6K to $5.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.